The European Medical Journal Presents: EMJ Gastroenterology 7.1 - European Medical Journal

The European Medical Journal Presents: EMJ Gastroenterology 7.1

London, United Kingdom, December 11, 2018

EMJ Gastroenterology 7.1 is now available, presenting a full review of UEG Week 2018, this year held in the Austrian capital: Vienna.

This year’s event was the biggest yet, with Prof Herbert Tilg, Chair of the UEG Scientific Committee, confirming it as “the most important forum to present gastrointestinal research.” Detailing results from the UNIFI Phase III trial into ustekinumab as an induction therapy for moderate-to-severely active ulcerative colitis, a comparison between laparoscopic ileocaecal resection and infliximab for the treatment of immunomodulator-refractory Crohn’s disease, and research from the USA into the risk factors for colorectal cancer in those aged 20–49 years, EMJ’s extensive Congress Review details all of the headline news disseminated at the event.

As always, the latest edition of EMJ Gastroenterology features an assortment of peer-reviewed articles sure to fascinate those working within the field, with topics ranging from the use of probiotics to prevent infantile colic to pathological considerations of colorectal polyps. Additionally, the eJournal contains key insights from members of the EMJ Gastroenterology Editorial Board, alongside a selection of captivating abstract reviews taken from the array of presentations on offer at this year’s UEG Week.

The EMJ team are certain this latest publication will provide a springboard for productive discussion and dissemination of the latest advances in digestive health, and hope the information presented inside will spark new developments within clinical practice.

 

Notes to Editors

About EMJ:

Renowned for being the only medical journal to review the biggest European congresses, six weeks after each event is held, the European Medical Journal is an independent, open-access eJournal dedicated to delivering first-class insights into ground-breaking changes, and advancements in the field.

Spanning sixteen therapeutic areas, including Innovations, Cardiology, Oncology, and more, each journal provides the reader with the latest from the field within our medical congress highlights, abstract reviews, and peer-reviewed articles to name but a few of its wide content selection. Flagship EMJ journals are also published quarterly, bringing an assortment of research and review papers from a variety of topics, alongside unique features and interviews. If you’re interested in receiving quarterly newsletters, and the latest publications straight to your inbox, please do subscribe for free: https://www.emjreviews.com/mailing-list/.

If you would like more information about this publication, please call Stacey Rivers at +44 (0) 1245 334450, or email [email protected].

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.